Ticker
EOLSCompany Name
EVOLUS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
---|---|---|---|
6/30/2025 | 0 | $ -18.65M | $ 247.46M |
3/31/2025 | 0 | $ -6.6M | $ 219.97M |
12/31/2024 | 41.12 | $ 5.52M | $ 227.05M |
9/30/2024 | 37.98 | $ 5.89M | $ 223.72M |
6/30/2024 | 11.1 | $ 19.31M | $ 214.46M |
3/31/2024 | 11.26 | $ 18.44M | $ 207.73M |
12/31/2023 | 0 | $ -20.69M | $ 209.69M |
9/30/2023 | 0 | $ -19.37M | $ 187.34M |
6/30/2023 | 0 | $ -6.96M | $ 175.95M |
3/31/2023 | 22.06 | $ 6.95M | $ 153.29M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Liabilities / Equity
(=) D/E
D/E for EVOLUS INC is calculated as follows: Liabilities [ $ 180.68M ] / Equity [ $ 35.09M ]
(=) D/E [ 5.15 ]
Minimum
Sep 30, 2021
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.3K |
---|---|
min | 0 |
max | 6.03 |
average | 1.39 |
median | 0.98 |
std | 1.31 |